Bayer Affirms FY2026 currency-adjusted Adj EPS Guidance of $1.20-$1.35 vs $1.25 Est; Affirms FY2026 currency-adjusted Sales Guidance of $52.109B-$54.451B vs $52.110B Est
Bayer (OTC:BAYRY) affirms FY2026 currency-adjusted Adj EPS guidance from $1.20-$1.35 to $1.20-$1.35 vs $1.25 analyst estimate. Affirms FY2026 currency-adjusted sales outlook from $52.109 billion-$54.451 billion to
Bayer said its earnings and sales targets for next year will stay the same as before. When a big company keeps its promises steady instead of raising or lowering them, it suggests things are going about as expected.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.